DIMENSION THERAPEUTICS Quality of science. Quality of life. Logo (EUIPO, 03/28/2017)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark DIMENSION THERAPEUTICS Quality of science. Quality of life. was filed as Figurative mark on 03/28/2017 at the European Union Intellectual Property Office. The current status of the mark is "Application withdrawn".
Logodesign (Wiener Klassifikation)
#Other parts of the human body, DNA band, cells, brains, sperms, hair roots (also 2.9.12) #One polygon #Polygons with dark surfaces or parts of surfaces
| Trademark form | Figurative mark |
| File reference | 016517534 |
| Application date | March 28, 2017 |
| Publication date | April 12, 2017 |
Trademark owner
840 Memorial Drive, 4th Floor
02139 Cambridge
US
02139 Cambridge
US
Trademark representatives
Arabellastr. 30
81925 München
DE
Objection / Complaint
07/12/2017: Likelihood of confusion
Trademark
Applicant
SIEMENS HEALTHCARE DIAGNOSTICS INC.
goods and services
1
Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo use in gene therapy; chemical products, reagents, and biomolecules used for scientific and medical purposes
5
Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, and fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction; Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders; Gene therapy and phrophylaxis products for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders
42
Biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; and companion diagnostics and assays services in the field of gene therapy design and delivery
44
Providing medical services, namely, gene therapy design and delivery services in the field of genetic diseases and disorders, providing medical services, namely, gene therapy design and delivery services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory and menopausal diseases and disorders; providing medical services, namely, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction
ID: 11016517534